BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Fiona LallooD Gareth R Evans

Abstract

Pathological mutations in BRCA1, BRCA2 and TP53 are associated with an increased risk of breast cancer. This study evaluated mutation frequency of these genes in early-onset breast cancer patients, and correlated this with family history and determined relative risks to family members. Patients with breast adenocarcinoma diagnosed 30 years were ascertained between 1980 and 1997. Family history was established and mutation screening of BRCA1, BRCA2 and TP53 genes was performed. Estimates of penetrance and relative risk were undertaken. DNA was obtained from 100/139 women. 17/36 familial cases had a BRCA1, BRCA2 or TP53 mutation. Of 64 non-familial cases, one BRCA2, two BRCA1 and two TP53 mutations were detected. Penetrance estimates (by age 70) for breast cancer were 84% for BRCA1 mutations and 91% for BRCA2 mutations and for ovarian cancer, 60% and 26%, respectively. Relative risks associated with mutations were consistent with previous studies. BRCA1 and BRCA2 mutations in patients with breast cancer 30 years are predicted strongly by family history. The majority of families with ovarian cancer were due to mutations in BRCA1/2 whereas these mutations only accounted for 30-50% of the excess breast cancers.

References

Apr 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·M OritaT Sekiya
Jan 1, 1988·Genetic Epidemiology·K LangeM Boehnke
Jan 18, 1996·The New England Journal of Medicine·M G FitzGeraldD A Haber
May 15, 1997·The New England Journal of Medicine·M KrainerD A Haber
Jun 8, 1999·Journal of the National Cancer Institute·J PetoM R Stratton
Jul 8, 2003·International Journal of Cancer. Journal International Du Cancer·Silvia de SanjoséOlga M Sinilnikova

❮ Previous
Next ❯

Citations

Jun 2, 2007·Breast Cancer Research and Treatment·Suzanna L ArcandPatricia N Tonin
Oct 24, 2009·Breast Cancer Research and Treatment·Gitana Maria AcetoErnesto Jorge Podestà
Aug 17, 2010·Breast Cancer Research and Treatment·Antonio Piñero Madrona
Mar 7, 2012·Breast Cancer Research and Treatment·Serena MasciariJudy E Garber
Apr 13, 2013·Breast Cancer Research and Treatment·Michelle G RathJudy E Garber
Jul 20, 2007·Current Treatment Options in Oncology·Diana S RosmanBoris Pasche
Mar 21, 2008·Nature Reviews. Cancer·Archie BleyerUNKNOWN Biology and Clinical Trials Subgroups of the US National Cancer Institute Progress Review Group in Adolescent and Young Adul
Jun 1, 2013·Journal of the National Cancer Institute·Ellen CopsonUNKNOWN POSH Study Steering Group
Feb 26, 2010·Cold Spring Harbor Perspectives in Biology·Magali OlivierPierre Hainaut
Jun 12, 2008·Annual Review of Genomics and Human Genetics·Clare Turnbull, Nazneen Rahman
Jun 14, 2012·BMC Cancer·Amanda Gonçalves SilvaAna C V Krepischi
Jul 31, 2013·PloS One·Gillian MitchellUNKNOWN International Sarcoma Kindred Study
Jun 18, 2014·PloS One·Juliana GiacomazziPatricia Ashton-Prolla
Feb 3, 2011·Breast Cancer Research and Treatment·M A DidragaP M Nederlof
Feb 9, 2012·Familial Cancer·Muhammad U RashidUte Hamann
Feb 24, 2016·Journal of Pediatric Surgery·John A SandovalAlpin D Malkan
Sep 8, 2010·Hematology/oncology Clinics of North America·Deborah Hemel, Susan M Domchek
May 23, 2009·Seminars in Oncology·Carey K AndersArchie Bleyer
Jan 17, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Siranoush ManoukianGabriella Della-Torre
Oct 16, 2010·Pediatric Blood & Cancer·Ramandeep S AroraJillian M Birch
Mar 24, 2012·Journal of Surgical Oncology·M GageL R Henry
May 4, 2011·The Breast Journal·Ramūnas JanavičiusLaimonas Griškevičius
Apr 8, 2014·Human Mutation·Junne KamiharaJudy E Garber
Nov 11, 2014·Journal of Surgical Oncology·Thereasa A RichBanu Arun
Nov 12, 2016·International Journal of Molecular Sciences·Vladimir N Uversky
May 28, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gaëlle BougeardThierry Frebourg
Jun 9, 2016·Genetics and Molecular Biology·Mariana Fitarelli-KiehlJuliana Giacomazzi
Dec 20, 2016·Revista da Associação Médica Brasileira·Deise Santiago Girão EugênioElvira F Souza
Nov 26, 2015·Revista da Associação Médica Brasileira·Giselly EncinasMaria Aparecida Azevedo Koike Folgueira
May 17, 2017·Familial Cancer·R O'SheaD J Gallagher
Aug 26, 2017·Plastic and Reconstructive Surgery·Niall M McInerneyMitchell H Brown
Aug 30, 2018·Pediatric Blood & Cancer·Rebecca H JohnsonArchie Bleyer
Aug 21, 2008·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Tadeusz DebniakJan Lubinski

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

© 2022 Meta ULC. All rights reserved